The occurrence of multiple sclerosis in Southern Lower Saxony: results of a 12-year field study
Wikström, J.; Ritter, G.; Poser, S.; Firnhaber, W.; Bauer, H.J.
Der Nervenarzt 48(9): 494-499
1977
ISSN/ISBN: 0028-2804 PMID: 917160 Document Number: 120586
Document emailed within 1 workday
Related Documents
Horáková, D.; Kýr, M.; Havrdová, E.; Doležal, O.; Lelková, P.; Pospíšilová, L.; Bergsland, N.; Dwyer, M.G.; Cox, J.L.; Hussein, S.; Seidl, Z.; Vaněčková, M.; Krásenský, J.; Zivadinov, R. 2010: Apolipoprotein e ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study Folia Biologica 56(6): 242-251Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Firnhaber, W. 1972: Multiple sclerosis. Methods and results of a geomedical study Fortschritte der Medizin 90(14): 551-554
Eife, K. 1971: The occurrence of bovine leucosis in Lower Saxony. Results of 5 years of blood testing (1965-1969). II. Importance of herd size in fighting leucosis Deutsche Tierärztliche Wochenschrift 78(18): 489-493
Thieme, D.; Langer, G.; Behrens, J. 2010: Survey of nurses about compression therapy of acute deep venous thrombosis. Field study in Saxony-Anhalt Pflege Zeitschrift 63(3): 162-167
Barta, L.; Kovács, G.; Tausz, I. 1987: Simultaneous occurrence of diabetes mellitus and multiple sclerosis Orvosi Hetilap 128(10): 507-508
Szobor, A. 1984: Simultaneous occurrence of multiple sclerosis and myasthenia gravis Orvosi Hetilap 125(19): 1127-1129
Boĭko, A.N.; Davydovskaia, M.V.; Demina, T.L.; Lashch, N.I.; Ovcharov, V.V.; Popova, E.V.; Popova, N.F.; Romashkin, A.V.; Boĭko, O.V.; Khachanova, N.V.; Sharanova, S.N.; Shchur, S.G.; Gusev, E.I. 2012: Efficacy and tolerability of long-term using of glatimer acetate (copaxone): a 10 year-study in the Moscow Municipal Multiple Sclerosis center Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112(2 Part 2): 86-92
Sloan, J.B.; Berk, M.A.; Gebel, H.M.; Fretzin, D.F. 1987: Multiple sclerosis and systemic lupus erythematosus. Occurrence in two generations of the same family Archives of Internal Medicine 147(7): 1317-1320
Harych, H. 1995: Worries about the job, unemployment and health status--initial results of a study in Saxony Gesundheitswesen 57(2): 82-85
Guize, L.; Ducimetière, P.; Consoli, S.M.; Kolsky, H.; Raynaud, P.; Walch, J.M.; Paul-Dauphin, A.; Duprat-Lomon, I. 2000: One-year follow-up of a population of patients with angina. Factors influencing mortality and occurrence of cardiovascular events. Results of the ELAN study Archives des Maladies du Coeur et des Vaisseaux 93(3): 227-237
Schiefer, U.; Gisolf, A.C.; Kirsch, J.; Selbmann, H.K.; Zrenner, E. 1996: Noise field screening. Results of a television field study for detection of visual field defects Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 93(5): 604-616
Vidović, T.; Cerovski, B.; Vidović, D.H.; Cerovski, J.; Novak-Laus, K. 2005: Inapparent visual field defects in multiple sclerosis patients Collegium Antropologicum 29(Suppl 1): 67-73
Lhermitte, F.; Marteau, R.; de Saxcé, H. 1987: Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up Revue Neurologique (Paris) 143(2): 98-107
Olcay, L.; Renda, Y.; Bakkaloğlu, A.; Topçu, M.; Diren, B.; Besim, A. 1994: Multiple sclerosis in a six-year-old boy (case report) Turkish Journal of Pediatrics 36(1): 81-85
Yonekawa, T.; Takahashi, J.; Higuchi, K.; Ihara, T. 2007: Hypogeusia in a 9-year-old girl with multiple sclerosis No to Hattatsu 39(5): 387-391
Trouillas, P.; Neuschwander, P.; Nighoghossian, N.; Adeleine, P.; Tremisi, P. 1989: Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years Revue Neurologique (Paris) 145(5): 369-377
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Fujimoto, N. 1989: A comparison of central visual field measurement by automated perimetry in optic neuritis due to multiple sclerosis and of unknown etiology Nippon Ganka Gakkai Zasshi 93(5): 581-586